Welcome to IPOhub. We are currently in beta version so do not hesitate to contact us if you'd like to report something.

Cytovac is a growing Danish biotech company, which has chosen to focus on development of a cancer treatment that uses the body’s own immune system.

Country:
Sweden (SE)
Sector:
HEALTH CARE
Website:
Status:
Active
Market:
NASDAQ FIRST NORTH SWEDEN
ISIN:
Ticker:
Order book id:
Type:
Share
Amount of instruments:
Market cap:
Par value:
Currency:
SEK
Segment:
First North Premier
Trade period:
Offers
Type
Price
Pre-money valuation
Time
Listing
Terms:
Type
Price
Pre-money valuation
Time
Listing
Terms
Additional information:
Owners before:
Company details
Address:
City/district:
Zip code:

Phones:
Email:

Registration number:
559162-3318
Registration date:
LEI code:
People
CEO:
Chairman of the board:
Board:

Number of employees:
Largest shareholders
Other
Short name:
Cytovac
First trade date:
Instruments and Offers
Type
Ticker
Isin
Market
SHARE
NASDAQ FIRST NORTH SWEDEN Sweden
Type
Price
Pre-money valuation
Time
Listing
News and media
System.Threading.Tasks.Task`1[System.Threading.Tasks.VoidTaskResult]